Cargando…

A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers

Neural network analyses of circulating miRNAs have shown potential as non-invasive screening tests for ovarian cancer. A clinically useful test would detect occult disease when complete cytoreduction is most feasible. Here we used murine xenografts to sensitize a neural network model to detect low v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gockley, Allison, Pagacz, Konrad, Fiascone, Stephen, Stawiski, Konrad, Holub, Nicole, Hasselblatt, Kathleen, Cramer, Daniel W., Fendler, Wojciech, Chowdhury, Dipanjan, Elias, Kevin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068948/ https://www.ncbi.nlm.nih.gov/pubmed/35530324 http://dx.doi.org/10.3389/fonc.2022.786154

Ejemplares similares

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer
por: Elias, Kevin M, et al.
Publicado: (2017)

Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
por: Brummelhuis, Iris S., et al.
Publicado: (2021)

A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs
por: Pagacz, Konrad, et al.
Publicado: (2020)

NormiRazor: tool applying GPU-accelerated computing for determination of internal references in microRNA transcription studies
por: Grabia, Szymon, et al.
Publicado: (2020)

Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non–muscle‐invasive bladder cancer (NMIBC): A cohort analysis
por: Jobczyk, Mateusz, et al.
Publicado: (2020)

Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis
por: Nowicka, Zuzanna, et al.
Publicado: (2019)

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2018)

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles
por: Elias, Kevin, et al.
Publicado: (2023)

Serum microRNAs – potent biomarkers for radiation biodosimetry
por: Tomasik, Bartłomiej, et al.
Publicado: (2018)

Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors
por: Zakrzewska, Magdalena, et al.
Publicado: (2019)

Fertility restoration in mice with chemotherapy induced ovarian failure using differentiated iPSCs
por: Elias, Kevin M., et al.
Publicado: (2023)

A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence
por: Komseli, Eirini-Stavroula, et al.
Publicado: (2018)

A prognostic system for epithelial ovarian carcinomas using machine learning
por: Grimley, Philip M., et al.
Publicado: (2021)

Correction to: A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence
por: Komseli, Eirini-Stavroula, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Evidence of Differential Effects of Vitamin D Receptor Variants on Epithelial Ovarian Cancer Risk by Predicted Vitamin D Status
por: Prescott, Jennifer, et al.
Publicado: (2014)

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
por: James, Nicole E., et al.
Publicado: (2018)

Ovarian type epithelial tumor of the tunica vaginalis with abdominal metastasis
por: Smith, Hugh, et al.
Publicado: (2018)

Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors
por: Barone, Angela, et al.
Publicado: (2020)

Expression and clinical significance of NCOA5 in epithelial ovarian cancer
por: Song, Xiaoping, et al.
Publicado: (2023)

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
por: Robak, Pawel, et al.
Publicado: (2021)

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021)

PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2021)

Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
por: Cheng, Meiying, et al.
Publicado: (2023)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
por: Hung, Jo-Ni, et al.
Publicado: (2022)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023)

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
por: Robak, Paweł, et al.
Publicado: (2020)

Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
por: Ahmed, Nuzhat, et al.
Publicado: (2013)

Corrigendum: PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2022)

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

TGF-β gene polimorphisms as risk factors for asthma control among clinic patients
por: Michał, Panek, et al.
Publicado: (2021)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
por: Jiang, Yifan, et al.
Publicado: (2020)

A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer
por: Song, Zixuan, et al.
Publicado: (2021)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Comparison of Laparoscopic and Open Surgery for Women With Early-Stage Epithelial Ovarian Cancer
por: Ran, Xuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8japtqklohsu96hq72pg84k5m